Efficient intracellular delivery of antisense oligonucleotide and pharmaceutical factors
Efficient intracellular delivery of antisense oligonucleotide and pharmaceutical factors
批准号:
08672481
负责人:
YOTSUYANAGI Tosihisa
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As a carrier for intracellular delivery of an antisense and plasmid DNA,synthetic oligopeptides were examined. The oligopeptide which consisted of nine amino acids was synthesized as the carrier with a peptide synthesizer. Various peptide which consisted of lysine, leucine, cysteine, and tryptophane were synthesized and purified by the liquid chromatoqraphy which the reverse-aspect column was installed. The aptitude as the intracellular introduction carrier of the deoxyribonucleic acid with this synthetic peptide was examined by using the HeLaS3 cell by the plasmid DNA which contained the CAT gene.The gene expression was not observed in peptide which consisted of lysine and leucine, but observed in peptide contained cysteine. The dimer was found with the mass spectrum and the gene expression ability disappeared when the disulfide linkage of the peptide was cut by the DTT processing. The CD measurement showed that peptide took the structure which consisted of two peptide chains. As a result of the gel electrophoresis, the DNA and peptide formed complex. It were confirmed the complex was taken into intracellular from the observation with confocus laser microscope. The gene expression have been observed even by cells another of the HeLaS3, such as CHO,L929, COS7 and HepG2 cells. The introduction efficiency has improved when tryptophane is introduced into peptide. It has been understood that the oligopeptide which consists of the basic amino acid and the hydrophobic amino acid with the disulfide bond has the ability to introduce the deoxyribonucleic acid into intracellular. It will be studied on reletionship between the secondary structure of peptide and the interaction with the deoxyribonucleic acid further in the future.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Ueda, I.Mizuno, T.Yotsuyanagi, T.Manabe, and S.Nakamura: "Intraperitoneal administration of alpha-tricalcium phosphate particles incorporated with carboplatin in rats bearing abdominal carcinomatosis" Drug Delivery System. 12(3). 175-179 (1997)
T.Ueda、I.Mizuno、T.Yotsuyanagi、T.Manabe 和 S.Nakamura:“在患有腹部癌病的大鼠中腹膜内施用与卡铂结合的 α-磷酸三钙颗粒”药物输送系统。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
植田 拓也.水野 勇 ら: "ラット癌性腹膜炎におけるカルボプラチン含有αーリン酸三カルシウム細粒の腹腔内投与における基礎的検討" Drug Deliv.Sys.12. 175-179 (1997)
Takuya Ueda、Isamu Mizuno 等:“腹腔内施用含卡铂的 α-磷酸三钙细颗粒治疗大鼠癌性腹膜炎的基础研究”Drug Deliv.Sys.12 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Fukahori, S.Akazu, H.Sato, and T.Yotsuyanagi: "Bacterial Susceptibility of Buthyl p-Hydroxybenzoate in the Presence of Polyoxyethylene Cetyl Ether" Biocontrol Sci.3. 47-49 (1998)
M.Fukahori、S.Akazu、H.Sato 和 T.Yotsuyanagi:“聚氧乙烯鲸蜡基醚存在下对羟基苯甲酸丁酯的细菌敏感性”生物防治 Sci.3。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M. Fukahori et al: "Relationship between uptake of p-hydroxybenzoicacid esterby E. coli" Chom. pharm. Bull. 44. 1567-1570 (1996)
M. Fukahori 等人:“大肠杆菌摄取对羟基苯甲酸酯之间的关系”Chom。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
田中 洵.小山 修 ら: "口腔内粘膜付着性軟膏の製剤特性:水溶性高分子-プラスチベース系" 薬剤学. 57. 8-15 (1997)
Tanaka, K., Koyama, Osamu 等人:“口腔粘膜粘附软膏的配方特征:水溶性聚合物-plastibase 系统”药理学 57. 8-15 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Pharmaceutical Research on Antisense Origonucleotide
-
批准号:06672150
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1994
-
负责人:YOTSUYANAGI Tosihisa
-
依托单位:
国内基金
海外基金
靶向 TTR 的新型 Oligonucleotide-GalNAc 偶联物的高效构建与设计
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:聂辉军
-
依托单位:
oligonucleotide探针及弗氏菌根际生态的研究
-
批准号:39170048
-
项目类别:面上项目
-
资助金额:3.8万元
-
批准年份:1991
-
负责人:张忠泽
-
依托单位: